Sinobioway Medicine(SZ:002581) Zheng Quan Zhi Xing·2025-07-30 16:36Group 1 - The company held its sixth board meeting on July 30, 2025, with all 11 directors participating and voting [1][2] - The board approved multiple amendments to the company's governance documents to enhance operational compliance and efficiency, including the Articles of Association and various committee rules [2][3][4] Group 2 - The board's resolutions require approval from the first extraordinary general meeting of shareholders in 2025 to be implemented [2][3] - All resolutions were passed unanimously with 11 votes in favor, indicating strong board consensus [3][4] Group 3 - Key amendments include revisions to the rules governing the board of directors, independent directors, audit committee, and other governance structures to improve transparency and accountability [4][5][6] - The company plans to hold its first extraordinary general meeting on August 15, 2025, to review the board's approved resolutions [36]